Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of metanephros development (GO:0072217) | 9.08139947 |
2 | negative regulation of interleukin-17 production (GO:0032700) | 8.17261970 |
3 | regulation of isotype switching to IgG isotypes (GO:0048302) | 8.12561404 |
4 | * positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 7.92833791 |
5 | regulation of T cell chemotaxis (GO:0010819) | 7.82989361 |
6 | positive regulation of T cell chemotaxis (GO:0010820) | 7.82989361 |
7 | positive regulation of B cell mediated immunity (GO:0002714) | 7.69997791 |
8 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 7.69997791 |
9 | regulation of MHC class II biosynthetic process (GO:0045346) | 7.46736017 |
10 | regulation of chemokine biosynthetic process (GO:0045073) | 6.98902255 |
11 | * regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 6.47239335 |
12 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 6.44568870 |
13 | positive regulation of T cell cytokine production (GO:0002726) | 6.41860070 |
14 | positive regulation of isotype switching (GO:0045830) | 6.35261651 |
15 | regulation of immunoglobulin secretion (GO:0051023) | 6.34818051 |
16 | regulation of lymphocyte chemotaxis (GO:1901623) | 6.30280005 |
17 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 6.15235059 |
18 | alpha-beta T cell activation involved in immune response (GO:0002287) | 6.15235059 |
19 | T cell differentiation involved in immune response (GO:0002292) | 6.15235059 |
20 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 6.12234769 |
21 | defense response to protozoan (GO:0042832) | 6.11428170 |
22 | regulation of regulatory T cell differentiation (GO:0045589) | 6.06692089 |
23 | positive regulation of steroid biosynthetic process (GO:0010893) | 6.04184516 |
24 | negative regulation of neurological system process (GO:0031645) | 5.95982015 |
25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.88957060 |
26 | negative regulation of T cell mediated immunity (GO:0002710) | 5.83007968 |
27 | regulation of immunoglobulin mediated immune response (GO:0002889) | 5.82882332 |
28 | positive regulation of muscle cell apoptotic process (GO:0010661) | 5.80580333 |
29 | regulation of chronic inflammatory response (GO:0002676) | 5.75364667 |
30 | regulation of B cell mediated immunity (GO:0002712) | 5.63302100 |
31 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 5.61224035 |
32 | positive regulation of humoral immune response (GO:0002922) | 5.60803917 |
33 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 5.60712461 |
34 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 5.48890792 |
35 | regulation of response to tumor cell (GO:0002834) | 5.45161429 |
36 | positive regulation of response to tumor cell (GO:0002836) | 5.45161429 |
37 | positive regulation of immune response to tumor cell (GO:0002839) | 5.45161429 |
38 | regulation of immune response to tumor cell (GO:0002837) | 5.45161429 |
39 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 5.38436446 |
40 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 5.38436446 |
41 | positive regulation of DNA recombination (GO:0045911) | 5.38302681 |
42 | leukocyte apoptotic process (GO:0071887) | 5.34353424 |
43 | positive regulation of immunoglobulin production (GO:0002639) | 5.33580007 |
44 | activated T cell proliferation (GO:0050798) | 5.30173526 |
45 | response to protozoan (GO:0001562) | 5.29705564 |
46 | regulation of smooth muscle cell apoptotic process (GO:0034391) | 5.24975586 |
47 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 5.20701935 |
48 | positive regulation of interleukin-17 production (GO:0032740) | 5.18780256 |
49 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.15714538 |
50 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 5.12375864 |
51 | negative regulation of kidney development (GO:0090185) | 5.10923978 |
52 | positive regulation of cell killing (GO:0031343) | 5.01704511 |
53 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.00105249 |
54 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.99577458 |
55 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.86665167 |
56 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 4.84819973 |
57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.84364235 |
58 | regulation of interleukin-1 beta secretion (GO:0050706) | 4.78259320 |
59 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.76833969 |
60 | positive regulation of monooxygenase activity (GO:0032770) | 4.75377762 |
61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.73990838 |
62 | positive regulation of interleukin-12 production (GO:0032735) | 4.71581192 |
63 | positive regulation of type 2 immune response (GO:0002830) | 4.67040331 |
64 | regulation of immunoglobulin production (GO:0002637) | 4.67038580 |
65 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.63044897 |
66 | regulation of cell killing (GO:0031341) | 4.62153482 |
67 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.60825094 |
68 | positive regulation of activated T cell proliferation (GO:0042104) | 4.57547899 |
69 | regulation of isotype switching (GO:0045191) | 4.54311382 |
70 | regulation of vitamin metabolic process (GO:0030656) | 4.44762108 |
71 | positive regulation of alcohol biosynthetic process (GO:1902932) | 4.35701090 |
72 | regulation of interleukin-1 secretion (GO:0050704) | 4.32412113 |
73 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.29863644 |
74 | regulation of T cell cytokine production (GO:0002724) | 4.29525174 |
75 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 4.28903678 |
76 | alpha-beta T cell differentiation (GO:0046632) | 4.25938118 |
77 | positive regulation of lymphocyte migration (GO:2000403) | 4.20512635 |
78 | protein import into nucleus, translocation (GO:0000060) | 4.19001686 |
79 | interferon-gamma production (GO:0032609) | 4.18750786 |
80 | regulation of response to interferon-gamma (GO:0060330) | 4.16543281 |
81 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.14050714 |
82 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.14050714 |
83 | positive regulation of leukocyte mediated immunity (GO:0002705) | 4.11813249 |
84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 4.11761435 |
85 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 4.07190610 |
86 | cellular response to interleukin-15 (GO:0071350) | 4.05009915 |
87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.04850628 |
88 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.04850628 |
89 | regulation of T-helper 1 type immune response (GO:0002825) | 4.03321850 |
90 | regulation of interleukin-17 production (GO:0032660) | 4.02640978 |
91 | negative regulation of B cell apoptotic process (GO:0002903) | 4.01490707 |
92 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.00257888 |
93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.98029512 |
94 | lymphocyte chemotaxis (GO:0048247) | 3.94414780 |
95 | positive regulation of T cell migration (GO:2000406) | 3.90954458 |
96 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.90159260 |
97 | regulation of fever generation (GO:0031620) | 3.89404823 |
98 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.86168813 |
99 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85639441 |
100 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.85222210 |
101 | regulation of growth of symbiont in host (GO:0044126) | 3.85222210 |
102 | negative regulation of growth of symbiont in host (GO:0044130) | 3.85222210 |
103 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.85222210 |
104 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.84962423 |
105 | positive regulation of heat generation (GO:0031652) | 3.83790661 |
106 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.82623140 |
107 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.79583271 |
108 | * positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 3.76789202 |
109 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.76386965 |
110 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.74803606 |
111 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.74505770 |
112 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.73941176 |
113 | negative regulation of interleukin-2 production (GO:0032703) | 3.72407801 |
114 | regulation of metanephros development (GO:0072215) | 3.69553586 |
115 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.69220624 |
116 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.64355170 |
117 | alpha-beta T cell activation (GO:0046631) | 3.60838779 |
118 | regulation of interleukin-12 production (GO:0032655) | 3.60186729 |
119 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.57563591 |
120 | positive regulation of adaptive immune response (GO:0002821) | 3.55888994 |
121 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.53954453 |
122 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50038044 |
123 | positive regulation of steroid metabolic process (GO:0045940) | 3.45047402 |
124 | positive regulation of phosphatase activity (GO:0010922) | 3.41810081 |
125 | positive regulation of T cell mediated immunity (GO:0002711) | 3.39573474 |
126 | regulation of activated T cell proliferation (GO:0046006) | 3.37970129 |
127 | regulation of lymphocyte migration (GO:2000401) | 3.36437255 |
128 | response to interleukin-15 (GO:0070672) | 3.34852342 |
129 | regulation of T cell migration (GO:2000404) | 3.34322439 |
130 | positive regulation of interleukin-1 production (GO:0032732) | 3.34010162 |
131 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 3.33567227 |
132 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.33295079 |
133 | positive regulation of osteoclast differentiation (GO:0045672) | 3.31090532 |
134 | tolerance induction (GO:0002507) | 3.29419485 |
135 | cellular response to nicotine (GO:0071316) | 3.26710386 |
136 | * regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 3.26648327 |
137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.26156471 |
138 | T cell proliferation (GO:0042098) | 3.25636462 |
139 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.24728151 |
140 | positive regulation of neutrophil migration (GO:1902624) | 3.24728151 |
141 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.13744622 |
142 | T cell activation involved in immune response (GO:0002286) | 3.06164399 |
143 | regulation of the force of heart contraction (GO:0002026) | 3.06056710 |
144 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.00657991 |
145 | * positive regulation of JAK-STAT cascade (GO:0046427) | 2.98296487 |
146 | positive regulation of T cell proliferation (GO:0042102) | 2.89297218 |
147 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.83246820 |
148 | positive regulation of interleukin-10 production (GO:0032733) | 2.78226512 |
149 | negative regulation of macrophage differentiation (GO:0045650) | 2.76347120 |
150 | regulation of osteoclast differentiation (GO:0045670) | 2.73340804 |
151 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.65729767 |
152 | regulation of interleukin-1 beta production (GO:0032651) | 2.65588887 |
153 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.60566281 |
154 | positive regulation of oxidoreductase activity (GO:0051353) | 2.59911061 |
155 | regulation of DNA recombination (GO:0000018) | 2.53875396 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.79492862 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.36268756 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.19475026 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.66479193 |
5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.30112984 |
6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.07579421 |
7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.83876988 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.75977142 |
9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.53363949 |
10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.46806345 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.91018252 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72037791 |
13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66103224 |
14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.62623265 |
15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.61714022 |
16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.54058352 |
17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.48427614 |
18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.41575917 |
19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.36026964 |
20 | MYC_22102868_ChIP-Seq_BL_Human | 2.34452478 |
21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.33762612 |
22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.29865276 |
23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24747807 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24416685 |
25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.23854886 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.23203250 |
27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.15038066 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12704154 |
29 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12394241 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 2.12228436 |
31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06470890 |
32 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.02081366 |
33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.97025934 |
34 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95373677 |
35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95316502 |
36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.95273666 |
37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92719967 |
38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92305135 |
39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87149729 |
40 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.84386954 |
41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81884324 |
42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.76024517 |
43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.75668211 |
44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72011438 |
45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66337163 |
46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62387881 |
47 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60360799 |
48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59364490 |
49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58676010 |
50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56477388 |
51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56164820 |
52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55122362 |
53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.55062794 |
54 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.51043624 |
55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50288238 |
56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48882417 |
57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.48461860 |
58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48163986 |
59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47627809 |
60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47439150 |
61 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.46311474 |
62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44043898 |
63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43149508 |
64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.41654218 |
65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40626712 |
66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36576667 |
67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35502584 |
68 | MAF_26560356_Chip-Seq_TH2_Human | 1.35450245 |
69 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.34295909 |
70 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33896787 |
71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32875803 |
72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30256745 |
73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29614978 |
74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.28440466 |
75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26540022 |
76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26499246 |
77 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.25692137 |
78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25478592 |
79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24628061 |
80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23815446 |
81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23009401 |
82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22237401 |
83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19488681 |
84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18635969 |
85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15879587 |
86 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15728165 |
87 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15728165 |
88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13253695 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13178949 |
90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12741282 |
91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12665699 |
92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12473774 |
93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12390243 |
94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10880739 |
95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.09877918 |
96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09819221 |
97 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05181575 |
98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04707007 |
99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03967551 |
100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03357492 |
101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03170513 |
102 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.01604651 |
103 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.99074703 |
104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98977453 |
105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97754166 |
106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96078852 |
107 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.95460784 |
108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94392163 |
109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93614312 |
110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93173972 |
111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92669922 |
112 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.91093115 |
113 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90828120 |
114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90352931 |
115 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.89180443 |
116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89000499 |
117 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.88971093 |
118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87646445 |
119 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87141515 |
120 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86138581 |
121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86070235 |
122 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86065479 |
123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85378448 |
124 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85283287 |
125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84987626 |
126 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83484588 |
127 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82897572 |
128 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82818886 |
129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82794920 |
130 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82129798 |
131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82115704 |
132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81004395 |
133 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79062566 |
134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78663691 |
135 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.78659847 |
136 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.78443719 |
137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77032529 |
138 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.76314500 |
139 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.76055179 |
140 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75004566 |
141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74849487 |
142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74745604 |
143 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.74680861 |
144 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74529426 |
145 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74491479 |
146 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.74184789 |
147 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73583418 |
148 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.72719703 |
149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72695507 |
150 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.72397556 |
151 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71696070 |
152 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.71252444 |
153 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.70555969 |
154 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70446204 |
155 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.70384691 |
156 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.68861433 |
157 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.66400475 |
158 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.65858898 |
159 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64995510 |
160 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.64928900 |
161 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.64854139 |
162 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62182727 |
163 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61462400 |
164 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.61410690 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 6.14406173 |
2 | MP0005671_abnormal_response_to | 4.76924584 |
3 | MP0003436_decreased_susceptibility_to | 4.43764215 |
4 | MP0009785_altered_susceptibility_to | 3.60350452 |
5 | MP0001853_heart_inflammation | 3.59546620 |
6 | * MP0001835_abnormal_antigen_presentation | 3.36647628 |
7 | MP0000685_abnormal_immune_system | 3.20610159 |
8 | MP0003763_abnormal_thymus_physiology | 3.06873615 |
9 | MP0003303_peritoneal_inflammation | 3.03058558 |
10 | MP0000465_gastrointestinal_hemorrhage | 2.96490341 |
11 | MP0009333_abnormal_splenocyte_physiolog | 2.88811511 |
12 | * MP0002405_respiratory_system_inflammati | 2.87926102 |
13 | MP0000604_amyloidosis | 2.80826446 |
14 | MP0006082_CNS_inflammation | 2.78895115 |
15 | * MP0005000_abnormal_immune_tolerance | 2.62100483 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.61277222 |
17 | MP0005387_immune_system_phenotype | 2.50901472 |
18 | MP0001790_abnormal_immune_system | 2.50901472 |
19 | * MP0001800_abnormal_humoral_immune | 2.50077525 |
20 | MP0002723_abnormal_immune_serum | 2.43749646 |
21 | MP0001873_stomach_inflammation | 2.40365377 |
22 | MP0010155_abnormal_intestine_physiology | 2.37783031 |
23 | MP0005025_abnormal_response_to | 2.36220770 |
24 | MP0003186_abnormal_redox_activity | 2.27765811 |
25 | MP0003724_increased_susceptibility_to | 2.15324703 |
26 | * MP0002420_abnormal_adaptive_immunity | 2.09850031 |
27 | MP0002452_abnormal_antigen_presenting | 2.07816603 |
28 | * MP0001819_abnormal_immune_cell | 2.07598833 |
29 | MP0001533_abnormal_skeleton_physiology | 2.06886805 |
30 | MP0003866_abnormal_defecation | 1.99046959 |
31 | MP0004947_skin_inflammation | 1.94218190 |
32 | MP0002398_abnormal_bone_marrow | 1.91125501 |
33 | MP0001501_abnormal_sleep_pattern | 1.85320208 |
34 | * MP0002419_abnormal_innate_immunity | 1.84489567 |
35 | MP0004510_myositis | 1.77161035 |
36 | * MP0001845_abnormal_inflammatory_respons | 1.75476297 |
37 | MP0000716_abnormal_immune_system | 1.68131451 |
38 | MP0002933_joint_inflammation | 1.63323078 |
39 | MP0003448_altered_tumor_morphology | 1.62793132 |
40 | MP0001881_abnormal_mammary_gland | 1.58745837 |
41 | MP0002166_altered_tumor_susceptibility | 1.54667535 |
42 | MP0009764_decreased_sensitivity_to | 1.50960124 |
43 | MP0002138_abnormal_hepatobiliary_system | 1.48134170 |
44 | * MP0000689_abnormal_spleen_morphology | 1.44271805 |
45 | MP0002006_tumorigenesis | 1.44061165 |
46 | MP0000703_abnormal_thymus_morphology | 1.42620789 |
47 | * MP0002722_abnormal_immune_system | 1.41623241 |
48 | MP0002429_abnormal_blood_cell | 1.37199582 |
49 | MP0010307_abnormal_tumor_latency | 1.32032548 |
50 | MP0003329_amyloid_beta_deposits | 1.31492113 |
51 | MP0005076_abnormal_cell_differentiation | 1.30320780 |
52 | MP0003453_abnormal_keratinocyte_physiol | 1.26995091 |
53 | MP0002132_abnormal_respiratory_system | 1.26413912 |
54 | MP0005166_decreased_susceptibility_to | 1.26053691 |
55 | MP0009780_abnormal_chondrocyte_physiolo | 1.17679134 |
56 | MP0008569_lethality_at_weaning | 1.15668832 |
57 | MP0002998_abnormal_bone_remodeling | 1.14562542 |
58 | MP0005501_abnormal_skin_physiology | 1.12994897 |
59 | * MP0004782_abnormal_surfactant_physiolog | 1.11702740 |
60 | MP0008469_abnormal_protein_level | 1.11648243 |
61 | MP0004808_abnormal_hematopoietic_stem | 1.11265461 |
62 | MP0003950_abnormal_plasma_membrane | 1.10132218 |
63 | MP0000858_altered_metastatic_potential | 1.09054428 |
64 | MP0005165_increased_susceptibility_to | 1.08984495 |
65 | MP0000343_altered_response_to | 1.06142563 |
66 | MP0005390_skeleton_phenotype | 1.05897906 |
67 | MP0005464_abnormal_platelet_physiology | 1.04682089 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 1.01636426 |
69 | MP0004147_increased_porphyrin_level | 0.98078445 |
70 | MP0010352_gastrointestinal_tract_polyps | 0.97013705 |
71 | MP0002396_abnormal_hematopoietic_system | 0.94594746 |
72 | MP0008961_abnormal_basal_metabolism | 0.90608789 |
73 | MP0000609_abnormal_liver_physiology | 0.90206231 |
74 | MP0001663_abnormal_digestive_system | 0.89903948 |
75 | MP0001727_abnormal_embryo_implantation | 0.89472842 |
76 | MP0000249_abnormal_blood_vessel | 0.88079318 |
77 | MP0001851_eye_inflammation | 0.87911986 |
78 | MP0000627_abnormal_mammary_gland | 0.85947962 |
79 | MP0005023_abnormal_wound_healing | 0.85541005 |
80 | MP0000490_abnormal_crypts_of | 0.82845002 |
81 | MP0009697_abnormal_copulation | 0.80671700 |
82 | MP0003075_altered_response_to | 0.77618059 |
83 | MP0002254_reproductive_system_inflammat | 0.76592692 |
84 | MP0002877_abnormal_melanocyte_morpholog | 0.76522855 |
85 | MP0003806_abnormal_nucleotide_metabolis | 0.76522365 |
86 | MP0003195_calcinosis | 0.75291540 |
87 | MP0008057_abnormal_DNA_replication | 0.75089031 |
88 | MP0009763_increased_sensitivity_to | 0.74958972 |
89 | MP0009765_abnormal_xenobiotic_induced | 0.74344164 |
90 | MP0005319_abnormal_enzyme/_coenzyme | 0.71760364 |
91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71730379 |
92 | MP0003795_abnormal_bone_structure | 0.68648447 |
93 | MP0003936_abnormal_reproductive_system | 0.68006942 |
94 | MP0003091_abnormal_cell_migration | 0.65924788 |
95 | MP0002282_abnormal_trachea_morphology | 0.63735509 |
96 | MP0003566_abnormal_cell_adhesion | 0.57427750 |
97 | MP0005397_hematopoietic_system_phenotyp | 0.56474288 |
98 | MP0001545_abnormal_hematopoietic_system | 0.56474288 |
99 | * MP0002019_abnormal_tumor_incidence | 0.56214407 |
100 | MP0002693_abnormal_pancreas_physiology | 0.55894988 |
101 | MP0005164_abnormal_response_to | 0.55465686 |
102 | MP0001216_abnormal_epidermal_layer | 0.53220831 |
103 | MP0003786_premature_aging | 0.51868150 |
104 | MP0002234_abnormal_pharynx_morphology | 0.51526423 |
105 | MP0005381_digestive/alimentary_phenotyp | 0.49742438 |
106 | MP0009840_abnormal_foam_cell | 0.49265438 |
107 | MP0002277_abnormal_respiratory_mucosa | 0.47965916 |
108 | * MP0002136_abnormal_kidney_physiology | 0.44650605 |
109 | MP0009643_abnormal_urine_homeostasis | 0.44431829 |
110 | MP0008770_decreased_survivor_rate | 0.43894231 |
111 | MP0000598_abnormal_liver_morphology | 0.43420916 |
112 | MP0010771_integument_phenotype | 0.42933065 |
113 | MP0003943_abnormal_hepatobiliary_system | 0.42445277 |
114 | MP0008872_abnormal_physiological_respon | 0.41525204 |
115 | MP0001348_abnormal_lacrimal_gland | 0.40252096 |
116 | MP0004142_abnormal_muscle_tone | 0.39722830 |
117 | MP0000477_abnormal_intestine_morphology | 0.38620699 |
118 | MP0008873_increased_physiological_sensi | 0.38002761 |
119 | MP0001243_abnormal_dermal_layer | 0.37957710 |
120 | MP0005310_abnormal_salivary_gland | 0.37849406 |
121 | MP0002089_abnormal_postnatal_growth/wei | 0.37377084 |
122 | MP0008007_abnormal_cellular_replicative | 0.35814566 |
123 | MP0002736_abnormal_nociception_after | 0.28865801 |
124 | MP0001502_abnormal_circadian_rhythm | 0.25658343 |
125 | MP0005636_abnormal_mineral_homeostasis | 0.24939694 |
126 | MP0003718_maternal_effect | 0.23823850 |
127 | MP0001764_abnormal_homeostasis | 0.23537766 |
128 | MP0001919_abnormal_reproductive_system | 0.22516784 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 7.09873064 |
2 | Optic neuritis (HP:0100653) | 6.89528555 |
3 | Retrobulbar optic neuritis (HP:0100654) | 6.89528555 |
4 | Orchitis (HP:0100796) | 6.23041953 |
5 | Myositis (HP:0100614) | 5.81917054 |
6 | T lymphocytopenia (HP:0005403) | 5.36797317 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.29097974 |
8 | Abnormality of T cell number (HP:0011839) | 5.25372084 |
9 | Increased density of long bones (HP:0006392) | 5.18501314 |
10 | Keratoconjunctivitis sicca (HP:0001097) | 4.75545436 |
11 | Persistence of primary teeth (HP:0006335) | 4.67934769 |
12 | Arterial thrombosis (HP:0004420) | 4.55505597 |
13 | Abnormality of the pons (HP:0007361) | 4.45763614 |
14 | Biconcave vertebral bodies (HP:0004586) | 4.35899573 |
15 | Keratoconjunctivitis (HP:0001096) | 4.30736768 |
16 | Hypoplasia of the pons (HP:0012110) | 4.00906894 |
17 | Pulmonary infiltrates (HP:0002113) | 3.98608942 |
18 | Interstitial pulmonary disease (HP:0006530) | 3.91338053 |
19 | Nasal polyposis (HP:0100582) | 3.90251305 |
20 | Autoimmune hemolytic anemia (HP:0001890) | 3.82927779 |
21 | Eczematoid dermatitis (HP:0000976) | 3.79650409 |
22 | Glucose intolerance (HP:0000833) | 3.76890293 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.75163545 |
24 | Abnormality of T cells (HP:0002843) | 3.70431057 |
25 | IgA deficiency (HP:0002720) | 3.66592215 |
26 | Joint swelling (HP:0001386) | 3.55452211 |
27 | Mediastinal lymphadenopathy (HP:0100721) | 3.40425688 |
28 | Delayed epiphyseal ossification (HP:0002663) | 3.39479639 |
29 | Severe combined immunodeficiency (HP:0004430) | 3.29783667 |
30 | Carpal bone hypoplasia (HP:0001498) | 3.23966569 |
31 | Abnormality of the nasal mucosa (HP:0000433) | 3.23530393 |
32 | Recurrent fungal infections (HP:0002841) | 3.20399551 |
33 | Vasculitis (HP:0002633) | 3.07071095 |
34 | Thrombocytosis (HP:0001894) | 2.97568985 |
35 | Recurrent bronchitis (HP:0002837) | 2.97267969 |
36 | Recurrent viral infections (HP:0004429) | 2.96539861 |
37 | Epiphyseal dysplasia (HP:0002656) | 2.92654841 |
38 | Autoimmune thrombocytopenia (HP:0001973) | 2.91125423 |
39 | Increased serum pyruvate (HP:0003542) | 2.90301961 |
40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.89995800 |
41 | Combined immunodeficiency (HP:0005387) | 2.88963769 |
42 | Abnormality of B cell number (HP:0010975) | 2.88506482 |
43 | B lymphocytopenia (HP:0010976) | 2.88506482 |
44 | Cutaneous melanoma (HP:0012056) | 2.86521522 |
45 | Type I transferrin isoform profile (HP:0003642) | 2.86100509 |
46 | Flat capital femoral epiphysis (HP:0003370) | 2.83034930 |
47 | Muscle fiber atrophy (HP:0100295) | 2.82657514 |
48 | Anorexia (HP:0002039) | 2.80641991 |
49 | Hypoproteinemia (HP:0003075) | 2.78431344 |
50 | Vitreoretinal degeneration (HP:0000655) | 2.74449370 |
51 | Mitochondrial inheritance (HP:0001427) | 2.73738241 |
52 | IgM deficiency (HP:0002850) | 2.73200601 |
53 | IgG deficiency (HP:0004315) | 2.72721204 |
54 | Pulmonary embolism (HP:0002204) | 2.71471967 |
55 | Gangrene (HP:0100758) | 2.69713618 |
56 | Hemoptysis (HP:0002105) | 2.69001711 |
57 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68194430 |
58 | Type 2 muscle fiber atrophy (HP:0003554) | 2.66492553 |
59 | Deep palmar crease (HP:0006191) | 2.63880207 |
60 | Chronic diarrhea (HP:0002028) | 2.62379744 |
61 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.61955748 |
62 | Myocardial infarction (HP:0001658) | 2.60040026 |
63 | Attenuation of retinal blood vessels (HP:0007843) | 2.59583262 |
64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56726336 |
65 | Reduced antithrombin III activity (HP:0001976) | 2.56620848 |
66 | Irregular vertebral endplates (HP:0003301) | 2.52863089 |
67 | Abnormal glucose tolerance (HP:0001952) | 2.52513154 |
68 | Acute necrotizing encephalopathy (HP:0006965) | 2.51872503 |
69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.51376522 |
70 | Thrombophlebitis (HP:0004418) | 2.49430562 |
71 | Arthralgia (HP:0002829) | 2.48099535 |
72 | Vertebral compression fractures (HP:0002953) | 2.46311682 |
73 | Small epiphyses (HP:0010585) | 2.46033613 |
74 | Esophageal varix (HP:0002040) | 2.44586640 |
75 | Pustule (HP:0200039) | 2.43383145 |
76 | Pulmonary fibrosis (HP:0002206) | 2.38411179 |
77 | Encephalitis (HP:0002383) | 2.37971816 |
78 | Chronic otitis media (HP:0000389) | 2.36075825 |
79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35266494 |
80 | Increased CSF lactate (HP:0002490) | 2.35078350 |
81 | Abnormality of the prostate (HP:0008775) | 2.34233356 |
82 | Abnormality of glycolysis (HP:0004366) | 2.33238636 |
83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33063472 |
84 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33063472 |
85 | Metaphyseal irregularity (HP:0003025) | 2.31911102 |
86 | Leukocytosis (HP:0001974) | 2.30794355 |
87 | Abnormality of T cell physiology (HP:0011840) | 2.30741960 |
88 | Aplastic anemia (HP:0001915) | 2.30418602 |
89 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.29768839 |
90 | Exertional dyspnea (HP:0002875) | 2.29520531 |
91 | Chest pain (HP:0100749) | 2.27626653 |
92 | Increased IgM level (HP:0003496) | 2.27268792 |
93 | Renal Fanconi syndrome (HP:0001994) | 2.25404054 |
94 | Premature loss of primary teeth (HP:0006323) | 2.23614817 |
95 | Posterior subcapsular cataract (HP:0007787) | 2.22723913 |
96 | Ureteral stenosis (HP:0000071) | 2.21807593 |
97 | Cupped ribs (HP:0000887) | 2.21120945 |
98 | Hypergammaglobulinemia (HP:0010702) | 2.20274406 |
99 | Oligomenorrhea (HP:0000876) | 2.19876601 |
100 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.19771230 |
101 | Hepatocellular necrosis (HP:0001404) | 2.18951600 |
102 | Peritonitis (HP:0002586) | 2.18596581 |
103 | Gingival bleeding (HP:0000225) | 2.17475023 |
104 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16726142 |
105 | Abnormality of the vertebral endplates (HP:0005106) | 2.15103302 |
106 | Glossoptosis (HP:0000162) | 2.14242353 |
107 | Keratitis (HP:0000491) | 2.13425299 |
108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12712570 |
109 | Cerebral hypomyelination (HP:0006808) | 2.12512658 |
110 | Submucous cleft hard palate (HP:0000176) | 2.11265765 |
111 | Abnormality of the pleura (HP:0002103) | 2.10336371 |
112 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.09419340 |
113 | Glomerulopathy (HP:0100820) | 2.08899621 |
114 | Abnormality of the pericardium (HP:0001697) | 2.08685232 |
115 | Irregular epiphyses (HP:0010582) | 2.07909148 |
116 | Hypertensive crisis (HP:0100735) | 2.07029297 |
117 | Fatigue (HP:0012378) | 2.06318157 |
118 | Meningitis (HP:0001287) | 2.06262442 |
119 | Aseptic necrosis (HP:0010885) | 2.06083648 |
120 | Recurrent abscess formation (HP:0002722) | 2.06045176 |
121 | Depressed nasal tip (HP:0000437) | 2.05704394 |
122 | Lymphoma (HP:0002665) | 2.04846861 |
123 | Thoracolumbar scoliosis (HP:0002944) | 2.04467225 |
124 | Amaurosis fugax (HP:0100576) | 2.03928723 |
125 | Abnormality of the nasal septum (HP:0000419) | 2.03054703 |
126 | Abnormality of eosinophils (HP:0001879) | 2.01501044 |
127 | Abnormal albumin level (HP:0012116) | 2.00853232 |
128 | Hypoalbuminemia (HP:0003073) | 2.00853232 |
129 | Ureteral obstruction (HP:0006000) | 2.00574500 |
130 | Progressive macrocephaly (HP:0004481) | 2.00494384 |
131 | Panhypogammaglobulinemia (HP:0003139) | 1.99089355 |
132 | Acute myeloid leukemia (HP:0004808) | 1.97330950 |
133 | Enlarged epiphyses (HP:0010580) | 1.96934954 |
134 | Abnormal protein glycosylation (HP:0012346) | 1.96436803 |
135 | Abnormal glycosylation (HP:0012345) | 1.96436803 |
136 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96436803 |
137 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96436803 |
138 | Vertigo (HP:0002321) | 1.96379817 |
139 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.95832394 |
140 | Exercise intolerance (HP:0003546) | 1.95220267 |
141 | Abnormality of macrophages (HP:0004311) | 1.94946173 |
142 | Increased intramyocellular lipid droplets (HP:0012240) | 1.94184514 |
143 | Obstructive lung disease (HP:0006536) | 1.93864167 |
144 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93864167 |
145 | Hypoplastic ischia (HP:0003175) | 1.93792705 |
146 | Acute encephalopathy (HP:0006846) | 1.93688459 |
147 | Increased serum lactate (HP:0002151) | 1.92584146 |
148 | Recurrent bacterial skin infections (HP:0005406) | 1.90926274 |
149 | Somatic mutation (HP:0001428) | 1.90909325 |
150 | Gastrointestinal stroma tumor (HP:0100723) | 1.90262179 |
151 | Osteolytic defects of the hand bones (HP:0009699) | 1.89587622 |
152 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89587622 |
153 | Subacute progressive viral hepatitis (HP:0006572) | 1.87494080 |
154 | Periodontitis (HP:0000704) | 1.87386282 |
155 | Thyroiditis (HP:0100646) | 1.87080198 |
156 | Hepatosplenomegaly (HP:0001433) | 1.81587739 |
157 | Arthropathy (HP:0003040) | 1.81096649 |
158 | Polyneuropathy (HP:0001271) | 1.77887336 |
159 | Eosinophilia (HP:0001880) | 1.77278226 |
160 | Absent frontal sinuses (HP:0002688) | 1.76631769 |
161 | Nausea (HP:0002018) | 1.75340670 |
162 | Restrictive lung disease (HP:0002091) | 1.75329977 |
163 | Abnormality of the peritoneum (HP:0002585) | 1.71460254 |
164 | Polycythemia (HP:0001901) | 1.70926669 |
165 | Diplopia (HP:0000651) | 1.68872686 |
166 | Abnormality of binocular vision (HP:0011514) | 1.68872686 |
167 | Stenosis of the external auditory canal (HP:0000402) | 1.66353722 |
168 | Lymphopenia (HP:0001888) | 1.65581554 |
169 | Anhidrosis (HP:0000970) | 1.65401139 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.96078127 |
2 | MAP4K1 | 5.36288243 |
3 | EIF2AK3 | 4.96201680 |
4 | MAP3K14 | 3.74149306 |
5 | EIF2AK1 | 3.63462779 |
6 | ITK | 3.29127631 |
7 | ZAP70 | 2.97809007 |
8 | JAK3 | 2.87320859 |
9 | TEC | 2.31986411 |
10 | PIM2 | 2.31763956 |
11 | IRAK3 | 2.21559285 |
12 | IKBKB | 2.16033137 |
13 | TSSK6 | 2.07498466 |
14 | TBK1 | 2.04744043 |
15 | CHUK | 2.03965313 |
16 | MAP3K3 | 1.99636524 |
17 | MST4 | 1.89194270 |
18 | CSK | 1.88886528 |
19 | MAP2K6 | 1.76564813 |
20 | BUB1 | 1.76275013 |
21 | FLT3 | 1.71265236 |
22 | EIF2AK2 | 1.69423349 |
23 | STK10 | 1.69315188 |
24 | WNK1 | 1.69254840 |
25 | IKBKE | 1.66172888 |
26 | TNK2 | 1.64651673 |
27 | JAK1 | 1.63378494 |
28 | PIM1 | 1.62135584 |
29 | EPHB1 | 1.60231902 |
30 | ADRBK2 | 1.58570487 |
31 | TAOK3 | 1.53815455 |
32 | CAMKK2 | 1.48731068 |
33 | TYK2 | 1.36316378 |
34 | MAP3K11 | 1.35768272 |
35 | BTK | 1.34104842 |
36 | VRK2 | 1.34071549 |
37 | HCK | 1.23160012 |
38 | TAOK1 | 1.17926677 |
39 | NME1 | 1.16655016 |
40 | BMX | 1.11636255 |
41 | FGFR4 | 1.11273435 |
42 | LCK | 1.10947872 |
43 | EEF2K | 1.09499179 |
44 | CLK1 | 1.04160531 |
45 | SYK | 1.02200408 |
46 | GSK3A | 1.01684371 |
47 | LRRK2 | 0.97741011 |
48 | PRKD3 | 0.96048941 |
49 | EPHA3 | 0.95494487 |
50 | GRK7 | 0.91461947 |
51 | MAP3K12 | 0.90355255 |
52 | TAOK2 | 0.89032674 |
53 | ALK | 0.88120565 |
54 | FGFR3 | 0.87861617 |
55 | RAF1 | 0.84357687 |
56 | STK24 | 0.84350389 |
57 | RPS6KB2 | 0.83224907 |
58 | ERBB3 | 0.82248399 |
59 | JAK2 | 0.78616830 |
60 | MAP2K3 | 0.75267248 |
61 | PRKCQ | 0.72834618 |
62 | TRIB3 | 0.72268833 |
63 | VRK1 | 0.70309729 |
64 | FES | 0.69732354 |
65 | PAK2 | 0.69101292 |
66 | GRK6 | 0.68484528 |
67 | LYN | 0.68448222 |
68 | AKT3 | 0.67681246 |
69 | MAP3K7 | 0.67395183 |
70 | FGFR1 | 0.64885652 |
71 | RPS6KA4 | 0.64504841 |
72 | BLK | 0.63625144 |
73 | BCKDK | 0.63406941 |
74 | PTK6 | 0.63168865 |
75 | MST1R | 0.60887717 |
76 | RIPK1 | 0.60431748 |
77 | BMPR2 | 0.59476590 |
78 | SIK2 | 0.59412272 |
79 | PRKCH | 0.58521437 |
80 | PAK4 | 0.58039865 |
81 | GRK1 | 0.57190335 |
82 | TGFBR2 | 0.56884070 |
83 | IRAK4 | 0.54038156 |
84 | EPHA2 | 0.52532321 |
85 | EGFR | 0.52397520 |
86 | MAP2K7 | 0.52248031 |
87 | CDK6 | 0.50982049 |
88 | MAP3K8 | 0.50639304 |
89 | PDGFRB | 0.50405789 |
90 | KIT | 0.48533361 |
91 | NME2 | 0.48181960 |
92 | MELK | 0.45946454 |
93 | PRKG2 | 0.45795540 |
94 | INSR | 0.45282745 |
95 | NEK9 | 0.43497604 |
96 | ABL1 | 0.43029187 |
97 | PLK3 | 0.42226804 |
98 | CDK8 | 0.41975595 |
99 | IGF1R | 0.41278022 |
100 | MAP3K10 | 0.40675403 |
101 | MAP3K5 | 0.40621902 |
102 | NUAK1 | 0.38278009 |
103 | CAMKK1 | 0.37396981 |
104 | ADRBK1 | 0.37334233 |
105 | MAPK15 | 0.36770307 |
106 | KDR | 0.36700254 |
107 | RPS6KA1 | 0.36425517 |
108 | MAPKAPK2 | 0.35226426 |
109 | RPS6KA5 | 0.33097417 |
110 | MKNK2 | 0.32335632 |
111 | CDK12 | 0.30634160 |
112 | ABL2 | 0.30061341 |
113 | ROCK2 | 0.29973321 |
114 | PKN2 | 0.29959210 |
115 | MAP3K13 | 0.29563451 |
116 | SIK3 | 0.28265038 |
117 | MAP3K1 | 0.28022341 |
118 | PKN1 | 0.26237244 |
119 | BMPR1B | 0.26161483 |
120 | TGFBR1 | 0.23941889 |
121 | MTOR | 0.23409372 |
122 | CSNK2A2 | 0.23368196 |
123 | CDK4 | 0.22954956 |
124 | NEK1 | 0.22787647 |
125 | RPS6KB1 | 0.22287768 |
126 | ZAK | 0.22009591 |
127 | NLK | 0.21940772 |
128 | STK4 | 0.21611286 |
129 | TLK1 | 0.21069904 |
130 | PDK1 | 0.20121705 |
131 | LMTK2 | 0.18620564 |
132 | PLK1 | 0.18586195 |
133 | PRKCD | 0.18516993 |
134 | PAK1 | 0.16824535 |
135 | PRKCB | 0.16241738 |
136 | PRKCA | 0.15947169 |
137 | MAPK4 | 0.15112478 |
138 | MARK3 | 0.12956151 |
139 | FGR | 0.12683384 |
140 | MATK | 0.11538597 |
141 | BCR | 0.08770182 |
142 | CSNK2A1 | 0.08209761 |
143 | PINK1 | 0.07989073 |
144 | ERBB4 | 0.07720566 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 6.35656625 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 5.83501496 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.79685509 |
4 | Asthma_Homo sapiens_hsa05310 | 4.96018668 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.91647980 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.04198201 |
7 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.14979815 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.87900703 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.73535289 |
10 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.40524804 |
11 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.26087492 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25036428 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04705948 |
14 | Protein export_Homo sapiens_hsa03060 | 2.04021430 |
15 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.01125138 |
16 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90892394 |
17 | Measles_Homo sapiens_hsa05162 | 1.87953571 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86761698 |
19 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.72140338 |
20 | Malaria_Homo sapiens_hsa05144 | 1.65507269 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57683471 |
22 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50004041 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.49714528 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48775322 |
25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.43791761 |
26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.43751941 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42793703 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35849114 |
29 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34949518 |
30 | Apoptosis_Homo sapiens_hsa04210 | 1.29042723 |
31 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25523968 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22533762 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06583768 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05073634 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.05035952 |
36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03765884 |
37 | RNA polymerase_Homo sapiens_hsa03020 | 1.01502130 |
38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93562235 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 0.86688700 |
40 | Influenza A_Homo sapiens_hsa05164 | 0.85853634 |
41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84218121 |
42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82763925 |
43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82261910 |
44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79454726 |
45 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.79335963 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 0.78970283 |
47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77555023 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74222279 |
49 | * Salmonella infection_Homo sapiens_hsa05132 | 0.73988712 |
50 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73722233 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71082807 |
52 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67890786 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66159826 |
54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65689622 |
55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63817323 |
56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63630808 |
57 | * Amoebiasis_Homo sapiens_hsa05146 | 0.61516064 |
58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59071163 |
59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58628637 |
60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58407717 |
61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57350025 |
62 | Shigellosis_Homo sapiens_hsa05131 | 0.56881562 |
63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53934492 |
64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50609283 |
65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48671282 |
66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46184872 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45870389 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.44294496 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38387186 |
70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35135624 |
71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34978567 |
72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34928105 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34693302 |
74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33545112 |
75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33257848 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33235715 |
77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31928872 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31623240 |
79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31189120 |
80 | Mineral absorption_Homo sapiens_hsa04978 | 0.29488864 |
81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27105696 |
82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26895538 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26518704 |
84 | RNA transport_Homo sapiens_hsa03013 | 0.25179829 |
85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25031150 |
86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24032284 |
87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23366365 |
88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23042633 |
89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20944530 |
90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20629952 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.19677403 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19233493 |
93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.18718237 |
94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18705760 |
95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18095065 |
96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17173135 |
97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16850052 |
98 | Platelet activation_Homo sapiens_hsa04611 | 0.16789977 |
99 | Ribosome_Homo sapiens_hsa03010 | 0.16604619 |
100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.16483698 |
101 | Homologous recombination_Homo sapiens_hsa03440 | 0.15890392 |
102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15617059 |
103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15350407 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15055791 |
105 | Spliceosome_Homo sapiens_hsa03040 | 0.14903408 |
106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14169249 |
107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12480595 |
108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12280020 |
109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12040094 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11862933 |
111 | RNA degradation_Homo sapiens_hsa03018 | 0.09890839 |
112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09775989 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.09277761 |
114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08940248 |
115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.08307018 |
116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.08210382 |
117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08099799 |
118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.05651124 |
119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05297428 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.05185915 |
121 | Purine metabolism_Homo sapiens_hsa00230 | 0.03471263 |
122 | Peroxisome_Homo sapiens_hsa04146 | 0.02791262 |
123 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.02680230 |
124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.02670734 |
125 | Prion diseases_Homo sapiens_hsa05020 | 0.02475580 |
126 | Bladder cancer_Homo sapiens_hsa05219 | 0.01950198 |
127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01823476 |
128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.01446394 |
129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.01422052 |
130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.01403524 |
131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.00915307 |
132 | Focal adhesion_Homo sapiens_hsa04510 | 0.00525021 |
133 | Phagosome_Homo sapiens_hsa04145 | 0.00374808 |
134 | Metabolic pathways_Homo sapiens_hsa01100 | -0.1030140 |
135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0857631 |
136 | Phototransduction_Homo sapiens_hsa04744 | -0.0671003 |
137 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0629039 |
138 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0549419 |
139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0507447 |
140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0457863 |
141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0303512 |
142 | Lysosome_Homo sapiens_hsa04142 | -0.0300825 |
143 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | -0.0187854 |